Follow
Alex Dmitrienko
Title
Cited by
Cited by
Year
Multiple testing problems in pharmaceutical statistics
A Dmitrienko, AC Tamhane, F Bretz
CRC press, 2009
388*2009
Subgroup identification based on differential effect search—a recursive partitioning method for establishing response to treatment in patient subpopulations
I Lipkovich, A Dmitrienko, J Denne, G Enas
Statistics in medicine 30 (21), 2601-2621, 2011
3442011
Tutorial in biostatistics: data‐driven subgroup identification and analysis in clinical trials
I Lipkovich, A Dmitrienko, R B D'Agostino Sr
Statistics in medicine 36 (1), 136-196, 2017
2832017
Analysis of clinical trials using SAS: a practical guide
A Dmitrienko
SAS institute, 2017
2482017
Innovative approaches for designing and analyzing adaptive dose-ranging trials
B Bornkamp, F Bretz, A Dmitrienko, G Enas, B Gaydos, CH Hsu, F König, ...
Journal of biopharmaceutical statistics 17 (6), 965-995, 2007
2172007
Traditional multiplicity adjustment methods in clinical trials
A Dmitrienko, R D'Agostino Sr
Statistics in Medicine 32 (29), 5172-5218, 2013
1542013
General multistage gatekeeping procedures
A Dmitrienko, AC Tamhane, BL Wiens
Biometrical Journal: Journal of Mathematical Methods in Biosciences 50 (5 …, 2008
1462008
Tree‐structured gatekeeping tests in clinical trials with hierarchically ordered multiple objectives
A Dmitrienko, BL Wiens, AC Tamhane, X Wang
Statistics in medicine 26 (12), 2465-2478, 2007
1302007
Multiple co-primary endpoints: medical and statistical solutions: a report from the multiple endpoints expert team of the Pharmaceutical Research and Manufacturers of America
W Offen, C Chuang-Stein, A Dmitrienko, G Littman, J Maca, L Meyerson, ...
Drug information journal 41 (1), 31-46, 2007
1252007
Pharmaceutical statistics using SAS: a practical guide
A Dmitrienko, C Chuang-Stein, RB D'Agostino Sr
SAS Institute, 2007
1242007
LY315920NA/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis
BG Zeiher, J Steingrub, PF Laterre, A Dmitrienko, Y Fukiishi, E Abraham, ...
Critical care medicine 33 (8), 1741-1748, 2005
1232005
Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failure
E Abraham, C Naum, V Bandi, D Gervich, SF Lowry, R Wunderink, ...
Critical care medicine 31 (3), 718-728, 2003
1212003
Methods for identification and confirmation of targeted subgroups in clinical trials: a systematic review
T Ondra, A Dmitrienko, T Friede, A Graf, F Miller, N Stallard, M Posch
Journal of biopharmaceutical statistics 26 (1), 99-119, 2016
1202016
Strategies for identifying predictive biomarkers and subgroups with enhanced treatment effect in clinical trials using SIDES
I Lipkovich, A Dmitrienko
Journal of biopharmaceutical statistics 24 (1), 130-153, 2014
1172014
Gatekeeping procedures with clinical trial applications
A Dmitrienko, AC Tamhane
Pharmaceutical Statistics: The Journal of Applied Statistics in the …, 2007
1162007
Multiplicity considerations in clinical trials
A Dmitrienko, RB D’Agostino Sr
New England Journal of Medicine 378 (22), 2115-2122, 2018
1112018
Key multiplicity issues in clinical drug development
A Dmitrienko, RB D'Agostino Sr, MF Huque
Statistics in medicine 32 (7), 1079-1111, 2013
1082013
Challenge of multiple co‐primary endpoints: a new approach
C Chuang‐Stein, P Stryszak, A Dmitrienko, W Offen
Statistics in medicine 26 (6), 1181-1192, 2007
802007
Mixtures of multiple testing procedures for gatekeeping applications in clinical trials
A Dmitrienko, AC Tamhane
Statistics in Medicine 30 (13), 1473-1488, 2011
702011
Stepwise gatekeeping procedures in clinical trial applications
A Dmitrienko, AC Tamhane, X Wang, X Chen
Biometrical Journal: Journal of Mathematical Methods in Biosciences 48 (6 …, 2006
672006
The system can't perform the operation now. Try again later.
Articles 1–20